These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Toxicity of antiretroviral therapy and implications for drug development. Carr A Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812 [No Abstract] [Full Text] [Related]
33. Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice. Cleijsen RM; van de Ende ME; Kroon FP; Lunel FV; Koopmans PP; Gras L; de Wolf F; Burger DM J Antimicrob Chemother; 2007 Oct; 60(4):897-900. PubMed ID: 17704117 [TBL] [Abstract][Full Text] [Related]
34. Virological failure and subsequent resistance profiles in individuals exposed to atazanavir. Stebbing J; Nathan B; Jones R; McKenna A; Powles T; Bower M; Holmes P; Gazzard B; Nelson M AIDS; 2007 Aug; 21(13):1826-8. PubMed ID: 17690587 [TBL] [Abstract][Full Text] [Related]
35. [New data on atazanavir/r]]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887 [No Abstract] [Full Text] [Related]